nodes	percent_of_prediction	percent_of_DWPC	metapath
Procainamide—SLC22A3—Progesterone—uterine cancer	0.261	0.358	CbGbCtD
Procainamide—SLC22A2—Progesterone—uterine cancer	0.154	0.212	CbGbCtD
Procainamide—SLC22A1—Progesterone—uterine cancer	0.134	0.184	CbGbCtD
Procainamide—SLC22A5—Dactinomycin—uterine cancer	0.128	0.176	CbGbCtD
Procainamide—CYP2D6—Progesterone—uterine cancer	0.0387	0.0532	CbGbCtD
Procainamide—CYP2D6—Doxorubicin—uterine cancer	0.0118	0.0162	CbGbCtD
Procainamide—Pericarditis—Medroxyprogesterone Acetate—uterine cancer	0.00458	0.0363	CcSEcCtD
Procainamide—SCN7A—myometrium—uterine cancer	0.00401	0.0467	CbGeAlD
Procainamide—Sunitinib—STK11—uterine cancer	0.00385	0.625	CrCbGaD
Procainamide—DNMT1—myometrium—uterine cancer	0.00308	0.0358	CbGeAlD
Procainamide—Supraventricular tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00302	0.024	CcSEcCtD
Procainamide—Hepatomegaly—Medroxyprogesterone Acetate—uterine cancer	0.0028	0.0222	CcSEcCtD
Procainamide—DNMT1—epithelium—uterine cancer	0.00242	0.0281	CbGeAlD
Procainamide—DNMT1—uterine cervix—uterine cancer	0.0024	0.0279	CbGeAlD
Procainamide—SCN7A—female reproductive system—uterine cancer	0.00234	0.0272	CbGeAlD
Procainamide—Sunitinib—FGFR2—uterine cancer	0.00231	0.375	CrCbGaD
Procainamide—Hepatic enzyme increased—Progesterone—uterine cancer	0.00231	0.0183	CcSEcCtD
Procainamide—DNMT1—decidua—uterine cancer	0.00228	0.0266	CbGeAlD
Procainamide—Hepatomegaly—Dactinomycin—uterine cancer	0.00218	0.0173	CcSEcCtD
Procainamide—DNMT1—endometrium—uterine cancer	0.00217	0.0252	CbGeAlD
Procainamide—SCN7A—female gonad—uterine cancer	0.00213	0.0248	CbGeAlD
Procainamide—DNMT1—mammalian vulva—uterine cancer	0.0021	0.0244	CbGeAlD
Procainamide—SCN4A—renal system—uterine cancer	0.00204	0.0237	CbGeAlD
Procainamide—DNMT1—uterus—uterine cancer	0.002	0.0232	CbGeAlD
Procainamide—Lightheadedness—Progesterone—uterine cancer	0.00196	0.0155	CcSEcCtD
Procainamide—SLC22A4—myometrium—uterine cancer	0.00191	0.0222	CbGeAlD
Procainamide—SLC22A2—renal system—uterine cancer	0.00187	0.0218	CbGeAlD
Procainamide—DNMT1—female reproductive system—uterine cancer	0.0018	0.0209	CbGeAlD
Procainamide—Hepatic failure—Progesterone—uterine cancer	0.00177	0.014	CcSEcCtD
Procainamide—SLC22A3—myometrium—uterine cancer	0.00174	0.0202	CbGeAlD
Procainamide—DNMT1—female gonad—uterine cancer	0.00163	0.019	CbGeAlD
Procainamide—Arthritis—Progesterone—uterine cancer	0.00163	0.013	CcSEcCtD
Procainamide—DNMT1—vagina—uterine cancer	0.00162	0.0189	CbGeAlD
Procainamide—SCN3A—decidua—uterine cancer	0.00162	0.0188	CbGeAlD
Procainamide—Hepatic failure—Medroxyprogesterone Acetate—uterine cancer	0.0016	0.0127	CcSEcCtD
Procainamide—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00159	0.0126	CcSEcCtD
Procainamide—SCN3A—renal system—uterine cancer	0.00159	0.0185	CbGeAlD
Procainamide—Pericarditis—Epirubicin—uterine cancer	0.00145	0.0115	CcSEcCtD
Procainamide—SLC22A4—decidua—uterine cancer	0.00141	0.0165	CbGeAlD
Procainamide—Psychotic disorder—Medroxyprogesterone Acetate—uterine cancer	0.0014	0.0111	CcSEcCtD
Procainamide—SLC22A4—renal system—uterine cancer	0.00139	0.0162	CbGeAlD
Procainamide—SCN7A—lymph node—uterine cancer	0.00137	0.0159	CbGeAlD
Procainamide—SLC22A3—uterine cervix—uterine cancer	0.00135	0.0157	CbGeAlD
Procainamide—SLC22A4—endometrium—uterine cancer	0.00134	0.0156	CbGeAlD
Procainamide—Pericarditis—Doxorubicin—uterine cancer	0.00134	0.0106	CcSEcCtD
Procainamide—SLC22A1—renal system—uterine cancer	0.00132	0.0154	CbGeAlD
Procainamide—Abdominal discomfort—Progesterone—uterine cancer	0.00131	0.0104	CcSEcCtD
Procainamide—SLC22A3—smooth muscle tissue—uterine cancer	0.00131	0.0153	CbGeAlD
Procainamide—SCN2A—vagina—uterine cancer	0.00131	0.0152	CbGeAlD
Procainamide—SCN3A—female reproductive system—uterine cancer	0.00127	0.0148	CbGeAlD
Procainamide—SLC22A3—renal system—uterine cancer	0.00126	0.0147	CbGeAlD
Procainamide—SLC22A5—myometrium—uterine cancer	0.00126	0.0147	CbGeAlD
Procainamide—Hepatic failure—Dactinomycin—uterine cancer	0.00125	0.0099	CcSEcCtD
Procainamide—BCHE—myometrium—uterine cancer	0.00123	0.0143	CbGeAlD
Procainamide—SLC22A3—endometrium—uterine cancer	0.00122	0.0142	CbGeAlD
Procainamide—Depression—Progesterone—uterine cancer	0.00122	0.00968	CcSEcCtD
Procainamide—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00945	CcSEcCtD
Procainamide—SLC22A3—mammalian vulva—uterine cancer	0.00118	0.0138	CbGeAlD
Procainamide—Body temperature increased—Carboplatin—uterine cancer	0.00117	0.00931	CcSEcCtD
Procainamide—SCN3A—vagina—uterine cancer	0.00115	0.0134	CbGeAlD
Procainamide—SCN5A—vagina—uterine cancer	0.00115	0.0133	CbGeAlD
Procainamide—Lethargy—Dactinomycin—uterine cancer	0.00114	0.00908	CcSEcCtD
Procainamide—SLC22A4—female reproductive system—uterine cancer	0.00111	0.0129	CbGeAlD
Procainamide—Depression—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00877	CcSEcCtD
Procainamide—SCN9A—lymph node—uterine cancer	0.00107	0.0125	CbGeAlD
Procainamide—DNMT1—lymph node—uterine cancer	0.00105	0.0122	CbGeAlD
Procainamide—Cardiac disorder—Progesterone—uterine cancer	0.00102	0.00808	CcSEcCtD
Procainamide—Rash maculo-papular—Etoposide—uterine cancer	0.00102	0.00807	CcSEcCtD
Procainamide—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00101	0.00804	CcSEcCtD
Procainamide—SLC22A3—female reproductive system—uterine cancer	0.00101	0.0118	CbGeAlD
Procainamide—SLC22A4—vagina—uterine cancer	0.00101	0.0117	CbGeAlD
Procainamide—SLC22A5—uterine cervix—uterine cancer	0.000982	0.0114	CbGeAlD
Procainamide—SLC22A1—vagina—uterine cancer	0.000958	0.0111	CbGeAlD
Procainamide—BCHE—uterine cervix—uterine cancer	0.000957	0.0111	CbGeAlD
Procainamide—BCHE—smooth muscle tissue—uterine cancer	0.00093	0.0108	CbGeAlD
Procainamide—Cardiac disorder—Medroxyprogesterone Acetate—uterine cancer	0.000923	0.00733	CcSEcCtD
Procainamide—SLC22A3—female gonad—uterine cancer	0.000921	0.0107	CbGeAlD
Procainamide—SLC22A5—renal system—uterine cancer	0.000919	0.0107	CbGeAlD
Procainamide—SLC22A3—vagina—uterine cancer	0.000915	0.0107	CbGeAlD
Procainamide—Neutropenia—Dactinomycin—uterine cancer	0.000906	0.00719	CcSEcCtD
Procainamide—Chills—Medroxyprogesterone Acetate—uterine cancer	0.000892	0.00708	CcSEcCtD
Procainamide—SLC22A5—endometrium—uterine cancer	0.000888	0.0103	CbGeAlD
Procainamide—Ill-defined disorder—Progesterone—uterine cancer	0.000887	0.00704	CcSEcCtD
Procainamide—Hepatomegaly—Epirubicin—uterine cancer	0.000886	0.00703	CcSEcCtD
Procainamide—Angioedema—Progesterone—uterine cancer	0.000873	0.00693	CcSEcCtD
Procainamide—BCHE—endometrium—uterine cancer	0.000865	0.0101	CbGeAlD
Procainamide—Malaise—Progesterone—uterine cancer	0.000862	0.00684	CcSEcCtD
Procainamide—ACHE—lymph node—uterine cancer	0.000853	0.00993	CbGeAlD
Procainamide—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.000848	0.00673	CcSEcCtD
Procainamide—BCHE—mammalian vulva—uterine cancer	0.000837	0.00974	CbGeAlD
Procainamide—Cardiac failure—Etoposide—uterine cancer	0.000832	0.0066	CcSEcCtD
Procainamide—Convulsion—Progesterone—uterine cancer	0.000828	0.00657	CcSEcCtD
Procainamide—Hepatomegaly—Doxorubicin—uterine cancer	0.000819	0.0065	CcSEcCtD
Procainamide—Pleural effusion—Epirubicin—uterine cancer	0.000818	0.0065	CcSEcCtD
Procainamide—SCN10A—lymph node—uterine cancer	0.000815	0.00949	CbGeAlD
Procainamide—Myalgia—Progesterone—uterine cancer	0.000814	0.00646	CcSEcCtD
Procainamide—Arthralgia—Progesterone—uterine cancer	0.000814	0.00646	CcSEcCtD
Procainamide—Agranulocytosis—Dactinomycin—uterine cancer	0.000807	0.0064	CcSEcCtD
Procainamide—Discomfort—Progesterone—uterine cancer	0.000804	0.00638	CcSEcCtD
Procainamide—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000803	0.00638	CcSEcCtD
Procainamide—BCHE—uterus—uterine cancer	0.000797	0.00928	CbGeAlD
Procainamide—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.000791	0.00628	CcSEcCtD
Procainamide—Confusional state—Progesterone—uterine cancer	0.000786	0.00624	CcSEcCtD
Procainamide—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000781	0.0062	CcSEcCtD
Procainamide—Cardiac arrest—Etoposide—uterine cancer	0.000772	0.00612	CcSEcCtD
Procainamide—Shock—Progesterone—uterine cancer	0.000767	0.00609	CcSEcCtD
Procainamide—Pleural effusion—Doxorubicin—uterine cancer	0.000757	0.00601	CcSEcCtD
Procainamide—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00075	0.00595	CcSEcCtD
Procainamide—Anorexia—Progesterone—uterine cancer	0.000743	0.0059	CcSEcCtD
Procainamide—SCN3A—lymph node—uterine cancer	0.000743	0.00865	CbGeAlD
Procainamide—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000737	0.00585	CcSEcCtD
Procainamide—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000737	0.00585	CcSEcCtD
Procainamide—SLC22A5—female reproductive system—uterine cancer	0.000736	0.00857	CbGeAlD
Procainamide—Hypotension—Progesterone—uterine cancer	0.000729	0.00578	CcSEcCtD
Procainamide—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000728	0.00578	CcSEcCtD
Procainamide—Flushing—Dactinomycin—uterine cancer	0.00072	0.00571	CcSEcCtD
Procainamide—BCHE—female reproductive system—uterine cancer	0.000717	0.00834	CbGeAlD
Procainamide—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000713	0.00565	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000711	0.00564	CcSEcCtD
Procainamide—Chills—Dactinomycin—uterine cancer	0.000696	0.00552	CcSEcCtD
Procainamide—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000695	0.00552	CcSEcCtD
Procainamide—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000692	0.00549	CcSEcCtD
Procainamide—Oliguria—Epirubicin—uterine cancer	0.00068	0.0054	CcSEcCtD
Procainamide—Decreased appetite—Progesterone—uterine cancer	0.000678	0.00538	CcSEcCtD
Procainamide—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000674	0.00535	CcSEcCtD
Procainamide—SLC22A5—female gonad—uterine cancer	0.00067	0.0078	CbGeAlD
Procainamide—SLC22A5—vagina—uterine cancer	0.000666	0.00775	CbGeAlD
Procainamide—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.00066	0.00524	CcSEcCtD
Procainamide—Neutropenia—Etoposide—uterine cancer	0.000656	0.00521	CcSEcCtD
Procainamide—SLC22A4—lymph node—uterine cancer	0.000651	0.00757	CbGeAlD
Procainamide—BCHE—vagina—uterine cancer	0.000648	0.00755	CbGeAlD
Procainamide—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000644	0.00511	CcSEcCtD
Procainamide—Feeling abnormal—Progesterone—uterine cancer	0.000643	0.0051	CcSEcCtD
Procainamide—Gastrointestinal pain—Progesterone—uterine cancer	0.000638	0.00506	CcSEcCtD
Procainamide—Oliguria—Doxorubicin—uterine cancer	0.000629	0.00499	CcSEcCtD
Procainamide—Ventricular tachycardia—Epirubicin—uterine cancer	0.000627	0.00497	CcSEcCtD
Procainamide—Ill-defined disorder—Dactinomycin—uterine cancer	0.000627	0.00497	CcSEcCtD
Procainamide—Urticaria—Progesterone—uterine cancer	0.00062	0.00492	CcSEcCtD
Procainamide—Body temperature increased—Progesterone—uterine cancer	0.000616	0.00489	CcSEcCtD
Procainamide—Abdominal pain—Progesterone—uterine cancer	0.000616	0.00489	CcSEcCtD
Procainamide—Renal failure—Etoposide—uterine cancer	0.000615	0.00488	CcSEcCtD
Procainamide—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000614	0.00487	CcSEcCtD
Procainamide—Malaise—Dactinomycin—uterine cancer	0.000609	0.00483	CcSEcCtD
Procainamide—CYP2D6—renal system—uterine cancer	0.000593	0.0069	CbGeAlD
Procainamide—SLC22A3—lymph node—uterine cancer	0.000592	0.00689	CbGeAlD
Procainamide—Agranulocytosis—Etoposide—uterine cancer	0.000584	0.00463	CcSEcCtD
Procainamide—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000582	0.00462	CcSEcCtD
Procainamide—Ventricular tachycardia—Doxorubicin—uterine cancer	0.00058	0.0046	CcSEcCtD
Procainamide—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000578	0.00459	CcSEcCtD
Procainamide—Myalgia—Dactinomycin—uterine cancer	0.000575	0.00456	CcSEcCtD
Procainamide—Hypersensitivity—Progesterone—uterine cancer	0.000575	0.00456	CcSEcCtD
Procainamide—Rash maculo-papular—Epirubicin—uterine cancer	0.00057	0.00452	CcSEcCtD
Procainamide—Discomfort—Dactinomycin—uterine cancer	0.000568	0.00451	CcSEcCtD
Procainamide—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000561	0.00446	CcSEcCtD
Procainamide—Asthenia—Progesterone—uterine cancer	0.00056	0.00444	CcSEcCtD
Procainamide—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000559	0.00443	CcSEcCtD
Procainamide—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000559	0.00443	CcSEcCtD
Procainamide—Pruritus—Progesterone—uterine cancer	0.000552	0.00438	CcSEcCtD
Procainamide—Thrombocytopenia—Dactinomycin—uterine cancer	0.00054	0.00428	CcSEcCtD
Procainamide—Diarrhoea—Progesterone—uterine cancer	0.000534	0.00423	CcSEcCtD
Procainamide—Rash maculo-papular—Doxorubicin—uterine cancer	0.000527	0.00418	CcSEcCtD
Procainamide—Anorexia—Dactinomycin—uterine cancer	0.000525	0.00417	CcSEcCtD
Procainamide—Flushing—Etoposide—uterine cancer	0.000521	0.00414	CcSEcCtD
Procainamide—Cardiac disorder—Etoposide—uterine cancer	0.000521	0.00414	CcSEcCtD
Procainamide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000521	0.00413	CcSEcCtD
Procainamide—Dizziness—Progesterone—uterine cancer	0.000516	0.00409	CcSEcCtD
Procainamide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000507	0.00402	CcSEcCtD
Procainamide—Hepatic failure—Epirubicin—uterine cancer	0.000506	0.00402	CcSEcCtD
Procainamide—Chills—Etoposide—uterine cancer	0.000504	0.004	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000502	0.00399	CcSEcCtD
Procainamide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.0005	0.00397	CcSEcCtD
Procainamide—Vomiting—Progesterone—uterine cancer	0.000496	0.00393	CcSEcCtD
Procainamide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000484	0.00384	CcSEcCtD
Procainamide—Decreased appetite—Dactinomycin—uterine cancer	0.000479	0.0038	CcSEcCtD
Procainamide—Dysgeusia—Etoposide—uterine cancer	0.000479	0.0038	CcSEcCtD
Procainamide—Renal impairment—Epirubicin—uterine cancer	0.000478	0.00379	CcSEcCtD
Procainamide—CYP2D6—female reproductive system—uterine cancer	0.000475	0.00553	CbGeAlD
Procainamide—Hepatic failure—Doxorubicin—uterine cancer	0.000468	0.00372	CcSEcCtD
Procainamide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000467	0.00371	CcSEcCtD
Procainamide—Cardiac failure—Epirubicin—uterine cancer	0.000466	0.0037	CcSEcCtD
Procainamide—Lethargy—Epirubicin—uterine cancer	0.000464	0.00368	CcSEcCtD
Procainamide—Nausea—Progesterone—uterine cancer	0.000463	0.00368	CcSEcCtD
Procainamide—Feeling abnormal—Dactinomycin—uterine cancer	0.000454	0.0036	CcSEcCtD
Procainamide—Ill-defined disorder—Etoposide—uterine cancer	0.000454	0.0036	CcSEcCtD
Procainamide—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000451	0.00358	CcSEcCtD
Procainamide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000449	0.00357	CcSEcCtD
Procainamide—Renal impairment—Doxorubicin—uterine cancer	0.000442	0.00351	CcSEcCtD
Procainamide—Malaise—Etoposide—uterine cancer	0.000441	0.0035	CcSEcCtD
Procainamide—Body temperature increased—Dactinomycin—uterine cancer	0.000436	0.00346	CcSEcCtD
Procainamide—Abdominal pain—Dactinomycin—uterine cancer	0.000436	0.00346	CcSEcCtD
Procainamide—Cardiac arrest—Epirubicin—uterine cancer	0.000433	0.00343	CcSEcCtD
Procainamide—CYP2D6—female gonad—uterine cancer	0.000432	0.00503	CbGeAlD
Procainamide—Cardiac failure—Doxorubicin—uterine cancer	0.000431	0.00342	CcSEcCtD
Procainamide—SLC22A5—lymph node—uterine cancer	0.000431	0.00501	CbGeAlD
Procainamide—Lethargy—Doxorubicin—uterine cancer	0.00043	0.00341	CcSEcCtD
Procainamide—Convulsion—Etoposide—uterine cancer	0.000424	0.00336	CcSEcCtD
Procainamide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00042	0.00333	CcSEcCtD
Procainamide—BCHE—lymph node—uterine cancer	0.000419	0.00488	CbGeAlD
Procainamide—Abdominal pain upper—Epirubicin—uterine cancer	0.000416	0.0033	CcSEcCtD
Procainamide—Discomfort—Etoposide—uterine cancer	0.000411	0.00326	CcSEcCtD
Procainamide—Hypersensitivity—Dactinomycin—uterine cancer	0.000406	0.00322	CcSEcCtD
Procainamide—Confusional state—Etoposide—uterine cancer	0.000402	0.00319	CcSEcCtD
Procainamide—Cardiac arrest—Doxorubicin—uterine cancer	0.0004	0.00318	CcSEcCtD
Procainamide—Asthenia—Dactinomycin—uterine cancer	0.000395	0.00314	CcSEcCtD
Procainamide—Thrombocytopenia—Etoposide—uterine cancer	0.000391	0.0031	CcSEcCtD
Procainamide—Eosinophilia—Epirubicin—uterine cancer	0.000389	0.00309	CcSEcCtD
Procainamide—Abdominal pain upper—Doxorubicin—uterine cancer	0.000385	0.00305	CcSEcCtD
Procainamide—Anorexia—Etoposide—uterine cancer	0.00038	0.00302	CcSEcCtD
Procainamide—Diarrhoea—Dactinomycin—uterine cancer	0.000377	0.00299	CcSEcCtD
Procainamide—Hypotension—Etoposide—uterine cancer	0.000373	0.00296	CcSEcCtD
Procainamide—Neutropenia—Epirubicin—uterine cancer	0.000368	0.00292	CcSEcCtD
Procainamide—Eosinophilia—Doxorubicin—uterine cancer	0.00036	0.00286	CcSEcCtD
Procainamide—Vomiting—Dactinomycin—uterine cancer	0.00035	0.00278	CcSEcCtD
Procainamide—Decreased appetite—Etoposide—uterine cancer	0.000347	0.00275	CcSEcCtD
Procainamide—Renal failure—Epirubicin—uterine cancer	0.000345	0.00274	CcSEcCtD
Procainamide—Neutropenia—Doxorubicin—uterine cancer	0.00034	0.0027	CcSEcCtD
Procainamide—Feeling abnormal—Etoposide—uterine cancer	0.000329	0.00261	CcSEcCtD
Procainamide—Nausea—Dactinomycin—uterine cancer	0.000327	0.0026	CcSEcCtD
Procainamide—Agranulocytosis—Epirubicin—uterine cancer	0.000327	0.0026	CcSEcCtD
Procainamide—Gastrointestinal pain—Etoposide—uterine cancer	0.000326	0.00259	CcSEcCtD
Procainamide—Bradycardia—Epirubicin—uterine cancer	0.00032	0.00254	CcSEcCtD
Procainamide—Renal failure—Doxorubicin—uterine cancer	0.000319	0.00253	CcSEcCtD
Procainamide—Urticaria—Etoposide—uterine cancer	0.000317	0.00252	CcSEcCtD
Procainamide—Body temperature increased—Etoposide—uterine cancer	0.000315	0.0025	CcSEcCtD
Procainamide—Abdominal pain—Etoposide—uterine cancer	0.000315	0.0025	CcSEcCtD
Procainamide—Agranulocytosis—Doxorubicin—uterine cancer	0.000303	0.0024	CcSEcCtD
Procainamide—Bradycardia—Doxorubicin—uterine cancer	0.000296	0.00235	CcSEcCtD
Procainamide—Hypersensitivity—Etoposide—uterine cancer	0.000294	0.00233	CcSEcCtD
Procainamide—Cardiac disorder—Epirubicin—uterine cancer	0.000292	0.00232	CcSEcCtD
Procainamide—Flushing—Epirubicin—uterine cancer	0.000292	0.00232	CcSEcCtD
Procainamide—Asthenia—Etoposide—uterine cancer	0.000286	0.00227	CcSEcCtD
Procainamide—Chills—Epirubicin—uterine cancer	0.000282	0.00224	CcSEcCtD
Procainamide—Pruritus—Etoposide—uterine cancer	0.000282	0.00224	CcSEcCtD
Procainamide—Diarrhoea—Etoposide—uterine cancer	0.000273	0.00217	CcSEcCtD
Procainamide—Flushing—Doxorubicin—uterine cancer	0.00027	0.00214	CcSEcCtD
Procainamide—Cardiac disorder—Doxorubicin—uterine cancer	0.00027	0.00214	CcSEcCtD
Procainamide—Dysgeusia—Epirubicin—uterine cancer	0.000268	0.00213	CcSEcCtD
Procainamide—Dizziness—Etoposide—uterine cancer	0.000264	0.00209	CcSEcCtD
Procainamide—Chills—Doxorubicin—uterine cancer	0.000261	0.00207	CcSEcCtD
Procainamide—Ill-defined disorder—Epirubicin—uterine cancer	0.000254	0.00202	CcSEcCtD
Procainamide—Vomiting—Etoposide—uterine cancer	0.000254	0.00201	CcSEcCtD
Procainamide—Dysgeusia—Doxorubicin—uterine cancer	0.000248	0.00197	CcSEcCtD
Procainamide—Malaise—Epirubicin—uterine cancer	0.000247	0.00196	CcSEcCtD
Procainamide—Convulsion—Epirubicin—uterine cancer	0.000237	0.00188	CcSEcCtD
Procainamide—Nausea—Etoposide—uterine cancer	0.000237	0.00188	CcSEcCtD
Procainamide—Ill-defined disorder—Doxorubicin—uterine cancer	0.000235	0.00187	CcSEcCtD
Procainamide—Myalgia—Epirubicin—uterine cancer	0.000233	0.00185	CcSEcCtD
Procainamide—Arthralgia—Epirubicin—uterine cancer	0.000233	0.00185	CcSEcCtD
Procainamide—Discomfort—Epirubicin—uterine cancer	0.00023	0.00183	CcSEcCtD
Procainamide—Malaise—Doxorubicin—uterine cancer	0.000229	0.00181	CcSEcCtD
Procainamide—Confusional state—Epirubicin—uterine cancer	0.000225	0.00179	CcSEcCtD
Procainamide—Shock—Epirubicin—uterine cancer	0.00022	0.00175	CcSEcCtD
Procainamide—Convulsion—Doxorubicin—uterine cancer	0.00022	0.00174	CcSEcCtD
Procainamide—Thrombocytopenia—Epirubicin—uterine cancer	0.000219	0.00174	CcSEcCtD
Procainamide—Myalgia—Doxorubicin—uterine cancer	0.000216	0.00171	CcSEcCtD
Procainamide—Arthralgia—Doxorubicin—uterine cancer	0.000216	0.00171	CcSEcCtD
Procainamide—Discomfort—Doxorubicin—uterine cancer	0.000213	0.00169	CcSEcCtD
Procainamide—Anorexia—Epirubicin—uterine cancer	0.000213	0.00169	CcSEcCtD
Procainamide—Hypotension—Epirubicin—uterine cancer	0.000209	0.00166	CcSEcCtD
Procainamide—Confusional state—Doxorubicin—uterine cancer	0.000209	0.00166	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000204	0.00162	CcSEcCtD
Procainamide—Shock—Doxorubicin—uterine cancer	0.000204	0.00162	CcSEcCtD
Procainamide—Thrombocytopenia—Doxorubicin—uterine cancer	0.000203	0.00161	CcSEcCtD
Procainamide—Anorexia—Doxorubicin—uterine cancer	0.000197	0.00157	CcSEcCtD
Procainamide—Decreased appetite—Epirubicin—uterine cancer	0.000194	0.00154	CcSEcCtD
Procainamide—Hypotension—Doxorubicin—uterine cancer	0.000193	0.00153	CcSEcCtD
Procainamide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000189	0.0015	CcSEcCtD
Procainamide—Feeling abnormal—Epirubicin—uterine cancer	0.000184	0.00146	CcSEcCtD
Procainamide—Gastrointestinal pain—Epirubicin—uterine cancer	0.000183	0.00145	CcSEcCtD
Procainamide—Decreased appetite—Doxorubicin—uterine cancer	0.00018	0.00143	CcSEcCtD
Procainamide—Urticaria—Epirubicin—uterine cancer	0.000178	0.00141	CcSEcCtD
Procainamide—Abdominal pain—Epirubicin—uterine cancer	0.000177	0.0014	CcSEcCtD
Procainamide—Body temperature increased—Epirubicin—uterine cancer	0.000177	0.0014	CcSEcCtD
Procainamide—Feeling abnormal—Doxorubicin—uterine cancer	0.000171	0.00135	CcSEcCtD
Procainamide—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000169	0.00134	CcSEcCtD
Procainamide—Hypersensitivity—Epirubicin—uterine cancer	0.000165	0.00131	CcSEcCtD
Procainamide—Urticaria—Doxorubicin—uterine cancer	0.000164	0.0013	CcSEcCtD
Procainamide—Abdominal pain—Doxorubicin—uterine cancer	0.000164	0.0013	CcSEcCtD
Procainamide—Body temperature increased—Doxorubicin—uterine cancer	0.000164	0.0013	CcSEcCtD
Procainamide—Asthenia—Epirubicin—uterine cancer	0.00016	0.00127	CcSEcCtD
Procainamide—Pruritus—Epirubicin—uterine cancer	0.000158	0.00126	CcSEcCtD
Procainamide—Diarrhoea—Epirubicin—uterine cancer	0.000153	0.00121	CcSEcCtD
Procainamide—Hypersensitivity—Doxorubicin—uterine cancer	0.000152	0.00121	CcSEcCtD
Procainamide—Asthenia—Doxorubicin—uterine cancer	0.000148	0.00118	CcSEcCtD
Procainamide—Dizziness—Epirubicin—uterine cancer	0.000148	0.00117	CcSEcCtD
Procainamide—Pruritus—Doxorubicin—uterine cancer	0.000146	0.00116	CcSEcCtD
Procainamide—Vomiting—Epirubicin—uterine cancer	0.000142	0.00113	CcSEcCtD
Procainamide—Diarrhoea—Doxorubicin—uterine cancer	0.000142	0.00112	CcSEcCtD
Procainamide—Dizziness—Doxorubicin—uterine cancer	0.000137	0.00109	CcSEcCtD
Procainamide—Nausea—Epirubicin—uterine cancer	0.000133	0.00105	CcSEcCtD
Procainamide—Vomiting—Doxorubicin—uterine cancer	0.000132	0.00104	CcSEcCtD
Procainamide—Nausea—Doxorubicin—uterine cancer	0.000123	0.000975	CcSEcCtD
Procainamide—SCN3A—Axon guidance—KRAS—uterine cancer	5.28e-05	0.000988	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—CTNNB1—uterine cancer	5.26e-05	0.000985	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—ERBB2—uterine cancer	5.25e-05	0.000983	CbGpPWpGaD
Procainamide—ACHE—Metabolism—STAR—uterine cancer	5.24e-05	0.000981	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AKR1B1—uterine cancer	5.24e-05	0.000981	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—POLD1—uterine cancer	5.23e-05	0.000978	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	5.19e-05	0.000971	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	5.18e-05	0.00097	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—MET—uterine cancer	5.13e-05	0.00096	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—FBXW7—uterine cancer	5.12e-05	0.000959	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—HRAS—uterine cancer	5.08e-05	0.000951	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—KRAS—uterine cancer	5.07e-05	0.000949	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—KRAS—uterine cancer	5.07e-05	0.000949	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—CTNNB1—uterine cancer	5.03e-05	0.000942	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	4.95e-05	0.000926	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—EP300—uterine cancer	4.89e-05	0.000916	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—KRAS—uterine cancer	4.89e-05	0.000915	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—KRAS—uterine cancer	4.89e-05	0.000915	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AKR1C1—uterine cancer	4.89e-05	0.000915	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—KRAS—uterine cancer	4.87e-05	0.000912	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—CTNNB1—uterine cancer	4.84e-05	0.000905	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—CTNNB1—uterine cancer	4.84e-05	0.000905	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—ESR1—uterine cancer	4.82e-05	0.000902	CbGpPWpGaD
Procainamide—ACHE—Phospholipid metabolism—PIK3CA—uterine cancer	4.75e-05	0.000889	CbGpPWpGaD
Procainamide—SCN9A—Axon guidance—HRAS—uterine cancer	4.69e-05	0.000878	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	4.69e-05	0.000877	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—EP300—uterine cancer	4.68e-05	0.000876	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AKR1B1—uterine cancer	4.68e-05	0.000876	CbGpPWpGaD
Procainamide—BCHE—Metabolism—STAR—uterine cancer	4.68e-05	0.000876	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—CTNNB1—uterine cancer	4.66e-05	0.000873	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—CTNNB1—uterine cancer	4.66e-05	0.000873	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—VEGFA—uterine cancer	4.63e-05	0.000867	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.62e-05	0.000865	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—CXCL8—uterine cancer	4.61e-05	0.000863	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—NRAS—uterine cancer	4.58e-05	0.000857	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—FBXW7—uterine cancer	4.57e-05	0.000856	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—HRAS—uterine cancer	4.53e-05	0.000847	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—EP300—uterine cancer	4.5e-05	0.000841	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—EP300—uterine cancer	4.5e-05	0.000841	CbGpPWpGaD
Procainamide—SCN3A—Axon guidance—HRAS—uterine cancer	4.49e-05	0.00084	CbGpPWpGaD
Procainamide—SCN7A—Developmental Biology—AKT1—uterine cancer	4.48e-05	0.000839	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—VEGFA—uterine cancer	4.43e-05	0.000829	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—NRAS—uterine cancer	4.38e-05	0.000819	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—RRM2—uterine cancer	4.36e-05	0.000816	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—EP300—uterine cancer	4.33e-05	0.000811	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—EP300—uterine cancer	4.33e-05	0.000811	CbGpPWpGaD
Procainamide—SCN2A—Axon guidance—HRAS—uterine cancer	4.31e-05	0.000807	CbGpPWpGaD
Procainamide—SCN4A—Axon guidance—HRAS—uterine cancer	4.31e-05	0.000807	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—VEGFA—uterine cancer	4.26e-05	0.000797	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—VEGFA—uterine cancer	4.26e-05	0.000797	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	4.25e-05	0.000796	CbGpPWpGaD
Procainamide—BCHE—Phospholipid metabolism—PIK3CA—uterine cancer	4.24e-05	0.000793	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—DCN—uterine cancer	4.23e-05	0.000792	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—NRAS—uterine cancer	4.21e-05	0.000787	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—NRAS—uterine cancer	4.21e-05	0.000787	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—STAR—uterine cancer	4.18e-05	0.000782	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AKR1B1—uterine cancer	4.18e-05	0.000782	CbGpPWpGaD
Procainamide—SCN1A—Axon guidance—HRAS—uterine cancer	4.16e-05	0.000778	CbGpPWpGaD
Procainamide—SCN10A—Axon guidance—HRAS—uterine cancer	4.16e-05	0.000778	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—HRAS—uterine cancer	4.14e-05	0.000775	CbGpPWpGaD
Procainamide—ACHE—Metabolism—POLD1—uterine cancer	4.11e-05	0.00077	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—VEGFA—uterine cancer	4.11e-05	0.000768	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—VEGFA—uterine cancer	4.11e-05	0.000768	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—NRAS—uterine cancer	4.06e-05	0.000759	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—NRAS—uterine cancer	4.06e-05	0.000759	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—VEGFA—uterine cancer	4.04e-05	0.000757	CbGpPWpGaD
Procainamide—SCN11A—Developmental Biology—AKT1—uterine cancer	4e-05	0.000748	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—NRAS—uterine cancer	4e-05	0.000748	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP11A1—uterine cancer	3.99e-05	0.000746	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	3.98e-05	0.000746	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—EP300—uterine cancer	3.95e-05	0.00074	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—KRAS—uterine cancer	3.94e-05	0.000737	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AKR1B1—uterine cancer	3.89e-05	0.000729	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—STAR—uterine cancer	3.89e-05	0.000729	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AKR1C1—uterine cancer	3.85e-05	0.00072	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—NRAS—uterine cancer	3.84e-05	0.000718	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—KRAS—uterine cancer	3.77e-05	0.000705	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AKR1C3—uterine cancer	3.76e-05	0.000705	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—ERBB2—uterine cancer	3.75e-05	0.000701	CbGpPWpGaD
Procainamide—CHRM2—SIDS Susceptibility Pathways—VEGFA—uterine cancer	3.74e-05	0.000701	CbGpPWpGaD
Procainamide—BCHE—Metabolism—POLD1—uterine cancer	3.67e-05	0.000687	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	3.66e-05	0.000685	CbGpPWpGaD
Procainamide—SCN8A—Developmental Biology—AKT1—uterine cancer	3.66e-05	0.000684	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—KRAS—uterine cancer	3.62e-05	0.000678	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—KRAS—uterine cancer	3.62e-05	0.000678	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	3.54e-05	0.000663	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—KRAS—uterine cancer	3.49e-05	0.000653	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—KRAS—uterine cancer	3.49e-05	0.000653	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—KRAS—uterine cancer	3.44e-05	0.000644	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AKR1C1—uterine cancer	3.43e-05	0.000643	CbGpPWpGaD
Procainamide—ACHE—Metabolism—RRM2—uterine cancer	3.43e-05	0.000642	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—HRAS—uterine cancer	3.35e-05	0.000627	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—uterine cancer	3.34e-05	0.000625	CbGpPWpGaD
Procainamide—ACHE—Metabolism—DCN—uterine cancer	3.33e-05	0.000623	CbGpPWpGaD
Procainamide—CHRM2—G alpha (i) signalling events—CXCL8—uterine cancer	3.32e-05	0.000622	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—KRAS—uterine cancer	3.3e-05	0.000618	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—CTNNB1—uterine cancer	3.28e-05	0.000614	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—POLD1—uterine cancer	3.28e-05	0.000614	CbGpPWpGaD
Procainamide—ACHE—Transmission across Chemical Synapses—HRAS—uterine cancer	3.26e-05	0.000611	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKR1B10—uterine cancer	3.2e-05	0.0006	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—HRAS—uterine cancer	3.2e-05	0.000599	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP11A1—uterine cancer	3.14e-05	0.000587	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—HRAS—uterine cancer	3.08e-05	0.000576	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—HRAS—uterine cancer	3.08e-05	0.000576	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AKR1C1—uterine cancer	3.07e-05	0.000574	CbGpPWpGaD
Procainamide—BCHE—Metabolism—RRM2—uterine cancer	3.06e-05	0.000573	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—POLD1—uterine cancer	3.06e-05	0.000572	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—EP300—uterine cancer	3.05e-05	0.00057	CbGpPWpGaD
Procainamide—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—uterine cancer	3.03e-05	0.000568	CbGpPWpGaD
Procainamide—ACHE—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.99e-05	0.00056	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—SRD5A2—uterine cancer	2.97e-05	0.000557	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—NDUFB11—uterine cancer	2.97e-05	0.000557	CbGpPWpGaD
Procainamide—BCHE—Metabolism—DCN—uterine cancer	2.97e-05	0.000556	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—HRAS—uterine cancer	2.97e-05	0.000555	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—HRAS—uterine cancer	2.97e-05	0.000555	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AKR1C3—uterine cancer	2.96e-05	0.000555	CbGpPWpGaD
Procainamide—SCN9A—Developmental Biology—AKT1—uterine cancer	2.96e-05	0.000553	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—STK11—uterine cancer	2.93e-05	0.000549	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—CYP19A1—uterine cancer	2.93e-05	0.000549	CbGpPWpGaD
Procainamide—SCN5A—Axon guidance—HRAS—uterine cancer	2.92e-05	0.000547	CbGpPWpGaD
Procainamide—BCHE—Transmission across Chemical Synapses—HRAS—uterine cancer	2.91e-05	0.000545	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—VEGFA—uterine cancer	2.89e-05	0.00054	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AKR1C1—uterine cancer	2.86e-05	0.000535	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—NRAS—uterine cancer	2.85e-05	0.000534	CbGpPWpGaD
Procainamide—SCN3A—Developmental Biology—AKT1—uterine cancer	2.83e-05	0.000529	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP11A1—uterine cancer	2.8e-05	0.000524	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—RRM2—uterine cancer	2.73e-05	0.000512	CbGpPWpGaD
Procainamide—SCN4A—Developmental Biology—AKT1—uterine cancer	2.72e-05	0.000508	CbGpPWpGaD
Procainamide—SCN2A—Developmental Biology—AKT1—uterine cancer	2.72e-05	0.000508	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—RNF43—uterine cancer	2.65e-05	0.000497	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—DCN—uterine cancer	2.65e-05	0.000497	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AKR1C3—uterine cancer	2.64e-05	0.000495	CbGpPWpGaD
Procainamide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL8—uterine cancer	2.64e-05	0.000494	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—CCL2—uterine cancer	2.63e-05	0.000493	CbGpPWpGaD
Procainamide—SCN10A—Developmental Biology—AKT1—uterine cancer	2.62e-05	0.00049	CbGpPWpGaD
Procainamide—SCN1A—Developmental Biology—AKT1—uterine cancer	2.62e-05	0.00049	CbGpPWpGaD
Procainamide—SLC22A2—Transmission across Chemical Synapses—HRAS—uterine cancer	2.6e-05	0.000487	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—RRM2—uterine cancer	2.55e-05	0.000477	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CCL2—uterine cancer	2.54e-05	0.000476	CbGpPWpGaD
Procainamide—ACHE—Neuronal System—HRAS—uterine cancer	2.5e-05	0.000468	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP11A1—uterine cancer	2.5e-05	0.000468	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—DCN—uterine cancer	2.47e-05	0.000463	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—KRAS—uterine cancer	2.45e-05	0.000459	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—INHBA—uterine cancer	2.43e-05	0.000454	CbGpPWpGaD
Procainamide—SLC22A1—Transmission across Chemical Synapses—HRAS—uterine cancer	2.42e-05	0.000454	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AKR1C3—uterine cancer	2.36e-05	0.000442	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CCL2—uterine cancer	2.35e-05	0.00044	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP11A1—uterine cancer	2.33e-05	0.000436	CbGpPWpGaD
Procainamide—ACHE—Metabolism—STK11—uterine cancer	2.31e-05	0.000432	CbGpPWpGaD
Procainamide—ACHE—Metabolism—CYP19A1—uterine cancer	2.31e-05	0.000432	CbGpPWpGaD
Procainamide—BCHE—Neuronal System—HRAS—uterine cancer	2.23e-05	0.000418	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—MTHFR—uterine cancer	2.2e-05	0.000412	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AKR1C3—uterine cancer	2.2e-05	0.000412	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKR1C1—uterine cancer	2.19e-05	0.000409	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.17e-05	0.000406	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—STAR—uterine cancer	2.15e-05	0.000403	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKR1B1—uterine cancer	2.15e-05	0.000403	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—HRAS—uterine cancer	2.09e-05	0.00039	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—CXCL8—uterine cancer	2.08e-05	0.00039	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.07e-05	0.000387	CbGpPWpGaD
Procainamide—BCHE—Metabolism—STK11—uterine cancer	2.06e-05	0.000385	CbGpPWpGaD
Procainamide—BCHE—Metabolism—CYP19A1—uterine cancer	2.06e-05	0.000385	CbGpPWpGaD
Procainamide—CHRM2—GPCR ligand binding—CXCL8—uterine cancer	2.01e-05	0.000376	CbGpPWpGaD
Procainamide—SLC22A2—Neuronal System—HRAS—uterine cancer	1.99e-05	0.000373	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.93e-05	0.000362	CbGpPWpGaD
Procainamide—ACHE—Metabolism of proteins—CTNNB1—uterine cancer	1.92e-05	0.00036	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CXCL8—uterine cancer	1.86e-05	0.000348	CbGpPWpGaD
Procainamide—SLC22A1—Neuronal System—HRAS—uterine cancer	1.86e-05	0.000348	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.84e-05	0.000345	CbGpPWpGaD
Procainamide—SCN5A—Developmental Biology—AKT1—uterine cancer	1.84e-05	0.000345	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—STK11—uterine cancer	1.84e-05	0.000344	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—CYP19A1—uterine cancer	1.84e-05	0.000344	CbGpPWpGaD
Procainamide—DNMT1—Gene Expression—AKT1—uterine cancer	1.74e-05	0.000325	CbGpPWpGaD
Procainamide—ACHE—Metabolism—MTHFR—uterine cancer	1.73e-05	0.000325	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—CYP19A1—uterine cancer	1.71e-05	0.000321	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—STK11—uterine cancer	1.71e-05	0.000321	CbGpPWpGaD
Procainamide—BCHE—Metabolism of proteins—CTNNB1—uterine cancer	1.71e-05	0.000321	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—POLD1—uterine cancer	1.69e-05	0.000316	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKR1C3—uterine cancer	1.68e-05	0.000315	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PGR—uterine cancer	1.64e-05	0.000307	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKR1C1—uterine cancer	1.58e-05	0.000295	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—YWHAE—uterine cancer	1.56e-05	0.000293	CbGpPWpGaD
Procainamide—BCHE—Metabolism—MTHFR—uterine cancer	1.55e-05	0.00029	CbGpPWpGaD
Procainamide—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.53e-05	0.000286	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FBXW7—uterine cancer	1.5e-05	0.000281	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—RRM2—uterine cancer	1.41e-05	0.000263	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—MTHFR—uterine cancer	1.38e-05	0.000259	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—DCN—uterine cancer	1.37e-05	0.000256	CbGpPWpGaD
Procainamide—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.36e-05	0.000255	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—STK11—uterine cancer	1.31e-05	0.000245	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CCL2—uterine cancer	1.31e-05	0.000244	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—MTHFR—uterine cancer	1.29e-05	0.000241	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP11A1—uterine cancer	1.29e-05	0.000241	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SOCS3—uterine cancer	1.23e-05	0.00023	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PTEN—uterine cancer	1.23e-05	0.000229	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKR1C3—uterine cancer	1.22e-05	0.000227	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDKN2B—uterine cancer	1.18e-05	0.00022	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—EP300—uterine cancer	1.17e-05	0.000219	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—IGF1R—uterine cancer	1.14e-05	0.000214	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—CXCL8—uterine cancer	1.14e-05	0.000213	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—SMAD3—uterine cancer	1.07e-05	0.000201	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—CXCL8—uterine cancer	1.03e-05	0.000193	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—FGFR2—uterine cancer	1.02e-05	0.000192	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PTEN—uterine cancer	9.65e-06	0.000181	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—CYP19A1—uterine cancer	9.47e-06	0.000177	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—STK11—uterine cancer	9.47e-06	0.000177	CbGpPWpGaD
Procainamide—ACHE—Metabolism—EP300—uterine cancer	9.2e-06	0.000172	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ESR1—uterine cancer	8.76e-06	0.000164	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—PIK3CA—uterine cancer	8.65e-06	0.000162	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PTEN—uterine cancer	8.61e-06	0.000161	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—NRAS—uterine cancer	8.28e-06	0.000155	CbGpPWpGaD
Procainamide—BCHE—Metabolism—EP300—uterine cancer	8.21e-06	0.000154	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CCL2—uterine cancer	7.71e-06	0.000144	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PTEN—uterine cancer	7.69e-06	0.000144	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—EP300—uterine cancer	7.33e-06	0.000137	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—PIK3CA—uterine cancer	7.21e-06	0.000135	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PTEN—uterine cancer	7.17e-06	0.000134	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—KRAS—uterine cancer	7.12e-06	0.000133	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—MTHFR—uterine cancer	7.11e-06	0.000133	CbGpPWpGaD
Procainamide—SLC22A3—Metabolism—AKT1—uterine cancer	7.06e-06	0.000132	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—EP300—uterine cancer	6.83e-06	0.000128	CbGpPWpGaD
Procainamide—ACHE—Metabolism—PIK3CA—uterine cancer	6.81e-06	0.000127	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—PIK3CA—uterine cancer	6.55e-06	0.000123	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—ERBB2—uterine cancer	6.43e-06	0.00012	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CXCL8—uterine cancer	6.1e-06	0.000114	CbGpPWpGaD
Procainamide—BCHE—Metabolism—PIK3CA—uterine cancer	6.07e-06	0.000114	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—HRAS—uterine cancer	6.06e-06	0.000113	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CDKN1B—uterine cancer	5.95e-06	0.000111	CbGpPWpGaD
Procainamide—CHRM2—GPCR downstream signaling—AKT1—uterine cancer	5.89e-06	0.00011	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—CTNNB1—uterine cancer	5.62e-06	0.000105	CbGpPWpGaD
Procainamide—ACHE—Metabolism—AKT1—uterine cancer	5.56e-06	0.000104	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PTEN—uterine cancer	5.48e-06	0.000103	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—PIK3CA—uterine cancer	5.42e-06	0.000102	CbGpPWpGaD
Procainamide—CHRM2—Signaling by GPCR—AKT1—uterine cancer	5.35e-06	0.0001	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—EP300—uterine cancer	5.23e-06	9.78e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—PIK3CA—uterine cancer	5.06e-06	9.46e-05	CbGpPWpGaD
Procainamide—BCHE—Metabolism—AKT1—uterine cancer	4.96e-06	9.29e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—VEGFA—uterine cancer	4.95e-06	9.27e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—NRAS—uterine cancer	4.89e-06	9.15e-05	CbGpPWpGaD
Procainamide—SLC22A2—Metabolism—AKT1—uterine cancer	4.43e-06	8.29e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—KRAS—uterine cancer	4.21e-06	7.88e-05	CbGpPWpGaD
Procainamide—SLC22A1—Metabolism—AKT1—uterine cancer	4.13e-06	7.73e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PTEN—uterine cancer	3.96e-06	7.41e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—PIK3CA—uterine cancer	3.87e-06	7.24e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—EP300—uterine cancer	3.77e-06	7.07e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—TP53—uterine cancer	3.74e-06	7e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—HRAS—uterine cancer	3.58e-06	6.7e-05	CbGpPWpGaD
Procainamide—CHRM2—Signaling Pathways—AKT1—uterine cancer	3.16e-06	5.91e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—PIK3CA—uterine cancer	2.79e-06	5.23e-05	CbGpPWpGaD
Procainamide—CYP2D6—Metabolism—AKT1—uterine cancer	2.28e-06	4.27e-05	CbGpPWpGaD
